Crespo P, Bustelo X R, Aaronson D S, Coso O A, Lopez-Barahona M, Barbacid M, Gutkind J S
Molecular Signaling Unit, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892, USA.
Oncogene. 1996 Aug 1;13(3):455-60.
The protein product of the human vav oncogene, Vav exhibits a number of structural motifs suggestive of a role in signal transduction pathways, including a leucine-rich region, a plekstrin homology (PH) domain, a cysteine-rich domain, two SH3 regions, an SH2 domain, and a central Dbl homology (DH) domain. However, the transforming pathway(s) activated by Vav has not yet been elucidated. Interestingly, DH domains are frequently found in guanine nucleotide-exchange factors for small GTP-binding proteins of the Ras and Rho families, and it has been recently shown that, whereas Ras controls the activation of mitogen activated kinases (MAPKs), two members of the Rho family of small GTPases, Rac 1 and Cdc42, regulate activity of stress activated protein kinases (SAPKs), also termed c-jun N-terminal kinases (JNKs). The structural similarity between Vav and other guanine nucleotide exchange factors for small GTP-binding proteins, together with the recent identification of biochemical routes specific for members of the Ras and Rho family of GTPases, prompted us to explore whether MAPK or JNK are downstream components of the Vav signaling pathways. Using the COS-7 cell transient expression system, we have found that neither Vav nor the product of the vav proto-oncogene, proto-Vav, can enhance the enzymatic activity of a coexpressed, epitope tagged MAPK. On the other hand, we have observed that, whereas proto-Vav can slightly elevate JNK/SAPK activity, oncogenic Vav potently activates JNK/SAPK to an extent comparable to that elicited by two guanine-nucleotide exchange factors for Rho family members, Dbl and Ost. We also show that point mutations in conserved residues within the cysteine rich and DH domains of Vav both prevent its ability to activate JNK/SAPK and render Vav oncogenically inactive. In addition, we found that coexpression of the Rac-1 N17 dominant inhibitory mutant dramatically diminishes JNK/SAPK stimulation by Vav, as well as reduces the focus-forming ability of Vav in NIH3T3 murine fibroblasts. Taken together, these findings provide the first evidence that Rac-1 and JNK are integral components of the Vav signaling pathway.
人类vav癌基因的蛋白质产物Vav具有许多结构基序,提示其在信号转导途径中发挥作用,包括富含亮氨酸的区域、普列克底物蛋白同源(PH)结构域、富含半胱氨酸的结构域、两个SH3区域、一个SH2结构域以及一个中央Dbl同源(DH)结构域。然而,Vav激活的转化途径尚未阐明。有趣的是,DH结构域常见于Ras和Rho家族小GTP结合蛋白的鸟嘌呤核苷酸交换因子中,最近研究表明,Ras控制丝裂原活化激酶(MAPK)的激活,而Rho家族小GTP酶的两个成员Rac 1和Cdc42调节应激激活蛋白激酶(SAPK)的活性,后者也称为c-jun N端激酶(JNK)。Vav与其他小GTP结合蛋白的鸟嘌呤核苷酸交换因子之间的结构相似性,以及最近对Ras和Rho家族GTP酶成员特异性生化途径的鉴定,促使我们探究MAPK或JNK是否为Vav信号通路的下游成分。利用COS-7细胞瞬时表达系统,我们发现Vav和vav原癌基因的产物原Vav均不能增强共表达的、表位标记的MAPK的酶活性。另一方面,我们观察到,原Vav能轻微提高JNK/SAPK活性,而致癌性Vav能有效激活JNK/SAPK,其激活程度与Rho家族成员的两个鸟嘌呤核苷酸交换因子Dbl和Ost所引发的激活程度相当。我们还表明,Vav富含半胱氨酸和DH结构域中保守残基的点突变既能阻止其激活JNK/SAPK的能力,又能使Vav失去致癌活性。此外,我们发现共表达Rac-1 N17显性抑制突变体可显著减弱Vav对JNK/SAPK的刺激作用,并降低Vav在NIH3T3小鼠成纤维细胞中的集落形成能力。综上所述,这些发现首次证明Rac-1和JNK是Vav信号通路的重要组成部分。